AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 34453212
Drug: Postoperative intravenous
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative intravenous somatostatin (250 μg/h over 120 h); n=99
Trial: 34941128
Drug: 50 mL
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mL of a 2% saline solution for bilateral nasal irrigation for 1 week, followed by 50 mL of a 0.9% normal saline solution for bilateral nasal irrigations.
Trial: 34941128
Drug: Routine guidance
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine guidance and 20 mL of normal saline atomized through inhalation.
Trial: 35039254
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese medicine Paishi decoction combined with laparoscopic ureterectomy
Trial: 34703056
Drug: ultrasound guided
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ultrasound guided SCPB with 5 mL ropivacaine 0.5%
Trial: 34374434
Drug: Scaling and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scaling and root planing (SRP) with adjunctive amoxicillin (500 mg) and metronidazole (200 mg) three times a day for 7 days
Trial: 34110746
Drug: Combination oral
RxNorm normalized name: PROBIOTIC COMBINATION ORAL CAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination oral nitroimidazole 500 mg twice a day for 7 days and simultaneous boric acid 600 mg daily per vagina for 30 days, followed by twice-weekly vaginal metronidazole gel for 5 months.
Trial: 34110746
Drug: Maintenance metronidazole
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maintenance metronidazole gel
Trial: 32903261
Drug: Oral stimulation
RxNorm normalized name: follicle stimulating hormone / luteinizing hormone Injection [Menopur]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral stimulation program (tactile extra-, peri-, and intraoral manipulation) once a day for 15 minutes over 10 days
Trial: 616901046
Drug: Direct oral
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Direct oral anticoagulants (DOACs) such as rivaroxaban and edoxaban
Trial: 33494795
Drug: Acetate Ringer’s
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetate Ringer’s solution
Trial: 34032376
Drug: Passive pedaling
RxNorm normalized name: orange peel extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Passive pedaling with mini bike, 20 min, twice a week for 3 months
Trial: 34157617
Drug: OxCapRT (oxaliplatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OxCapRT (oxaliplatin 85 mg/m2 on Days 1, 15, and 29; capecitabine 625 mg/m2 orally twice daily on days of radiotherapy)
Trial: 34157617
Drug: CarPacRT (carboplatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CarPacRT (carboplatin AUC2; paclitaxel 50 mg/m2 on Days 1, 8, 15, 22, and 29)
Trial: 33300239
Drug: Active, mandible
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active, mandible protruded oral appliance (OAa)
Trial: 32894540
Drug: Leptin (Lep)
RxNorm normalized name: leptin
DrugBank: Leptin (DB05098)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leptin (Lep) at concentrations of 5-320 ng/mL
Trial: 35896277
Drug: Angiotensin-converting enzyme
RxNorm normalized name: ACE - Angiotensin-converting enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin-converting enzyme inhibitor–based therapy (fixed combination of perindopril and indapamide)
Trial: 35896277
Drug: Angiotensin-converting enzyme
RxNorm normalized name: ACE - Angiotensin-converting enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin-converting enzyme inhibitor–based therapy
Trial: 33871411
Drug: Real-time medication
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Real-time medication monitoring (RTMM) device (Wisepill) with SMS reminders
Trial: 35530564
Drug: 0.1% TXA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% TXA 1000 mg (10 mL) in 1 L of irrigation solution of sterile wash (glycine) during surgery
Trial: 35530564
Drug: Distilled water
RxNorm normalized name: Distilled Water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Distilled water (placebo) in 1 L of irrigation solution of sterile wash (glycine) during surgery
Trial: 33495919
Drug: Nafamostat mesylate
RxNorm normalized name: mesylate
DrugBank: Nafamostat (DB12598)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Nafamostat mesylate (NM) 20 mg
Trial: 35938913
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (alteplase + endovascular treatment)
Trial: 33397429
Drug: Oral Ivermectin
RxNorm normalized name: Ivermectin
DrugBank: Ivermectin (DB00602)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral Ivermectin at a single dose of 0.2 mg/kg for outpatient and inpatient groups.
Trial: 33397429
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment regimen for mild and moderate COVID-19 plus Ivermectin.
Trial: 33397429
Drug: Hydroxychloroquine sulfate
RxNorm normalized name: Hydroxychloroquine Sulfate
DrugBank: Hydroxychloroquine (DB01611)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydroxychloroquine sulfate at a dose of 400 mg twice a day for the first day and 200 mg twice a day for seven subsequent days for outpatient control group.
Trial: 33397429
Drug: 200/50 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200/50 mg Lopinavir/Ritonavir twice a day for seven days plus five doses of 44 mcg Interferon beta-1a every other day for inpatient control group.
Trial: 32011447
Drug: Chinese herbal
RxNorm normalized name: GINGER 28 mg in 100 mL TOPICAL OIL [Pain Relief Honzo Seika Chinese Herbal Aroma Oil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese herbal medicine Shen-Qi Hua-Yu formula
Trial: 32759183
Drug: physician choice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: physician choice chemotherapy
Trial: 35108791
Drug: Tamsulosin 0.4
RxNorm normalized name: tamsulosin 0.4 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.4 mg for 7 days
Trial: 32088664
Drug: Slow breathing
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow breathing exercise (daily training for 8 weeks)
Trial: 35365371
Drug: Sodium selenite
RxNorm normalized name: Sodium selenite
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Sodium selenite (200 μg/day)
Trial: 35365371
Drug: Se-enriched yeast
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Se-enriched yeast (200 μg/day)
Trial: 33443719
Drug: Probiotic supplement
RxNorm normalized name: Align Probiotic Supplement Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic supplement (Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07)
Trial: 32732334
Drug: EarlyCDT‐Lung test
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EarlyCDT‐Lung test plus low‐dose CT scanning 6‐monthly for up to 2 years
Trial: 32270635
Drug: Articular injection
RxNorm normalized name: PHOSPHORUS P-32 5 mCi in 1 mL INTRA-ARTICULAR INJECTION, SUSPENSION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Articular injection of sodium hyaluronate
Trial: 34727277
Drug: Pre-treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-treatment group (400 mg celecoxib at 4 h before THA, 200 mg at 4 h after THA, then 200 mg every 12 h until 72 h post-operation)
Trial: 32436913
Drug: Longer etching
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Longer etching time, total-etch adhesive system, and EDTA pre-treatment of sclerotic dentin in cervical wedge-shaped defects
Trial: 33217117
Drug: Dapagliflozin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapagliflozin (10 mg bid)
Trial: 36280012
Drug: PMBE (1322
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PMBE (1322 mg PMBE)
Trial: 36280012
Drug: Placebo (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0 mg PMBE)
Trial: 36146919
Drug: Double portion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double portion of food (e.g., double portion of banana, carrot, loaf cake, salami)
Trial: 36146919
Drug: Reference portion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference portion of food (e.g., half a banana, half a large peeled carrot, a slice of loaf cake, half a salami stick)
Trial: 33938674
Drug: US guided
FDA approved: no
EMA approved: no
PMDA approved: no
Description: US guided SGB with 5 mL of 0.5% bupivacaine and multimodal systemic analgesia (Group A)
Trial: 33239306
Drug: Endovascular treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular treatment (EVT) in the ESCAPE-NA1 trial
Trial: 33239306
Drug: Endovascular treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular treatment (EVT) in the DAWN trial
Trial: 33239306
Drug: Endovascular treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular treatment (EVT) in the DEFUSE-3 trial
Trial: 70634317
Drug: Cell treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cell treatment (all groups pooled)
Trial: 34142392
Drug: Nigella sativa
RxNorm normalized name: NIGELLA SATIVA SEED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nigella sativa oil extract (500 mg per day for 8 weeks)
Trial: 36268946
Drug: Dexamethasone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (10 mg) and articaine (68 mg) mixture
Trial: 33596969
Drug: Topical combination
RxNorm normalized name: soap TOPICAL COMBINATION PACKAGE (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical combination of clonidine and pentoxifylline
Trial: 34274494
Drug: COVID-19 treatments
RxNorm normalized name: covid-19, protein subunit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COVID-19 treatments (specific treatments not detailed)
Trial: 35844438
Drug: ERAS plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ERAS plus integrated traditional Chinese and Western medicine
Trial: 35844438
Drug: Routine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine treatment and care
Trial: 36194218
Drug: Cefepime 2
RxNorm normalized name: cefepime 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefepime 2 g/enmetazobactam 0.5 g
Trial: 36194218
Drug: Piperacillin 4
RxNorm normalized name: piperacillin 4000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piperacillin 4 g/tazobactam 0.5 g
Trial: 34274500
Drug: Balanced anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balanced anesthesia (volatile inhalational and intravenous agents)
Trial: 35963082
Drug: Xylocaine 10%
RxNorm normalized name: Xylocaine 10% Oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xylocaine 10% pump spray
Trial: 35005871
Drug: Novel hyaluronic
RxNorm normalized name: hyaluronate
DrugBank: Hyaluronic acid (DB08818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Novel hyaluronic acid injectable gel with 0.3% lidocaine (test device)
Trial: 35005871
Drug: Commercially available
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Commercially available injectable hyaluronic acid gel with 0.3% lidocaine (comparator)
Trial: 33169863
Drug: Daily 1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily 1,000 IU vitamin D(3)
Trial: 32540319
Drug: Survey on
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Survey on dentists' beliefs and behaviors concerning antibiotic prophylaxis (AP)
Trial: 33470637
Drug: Interleukin-1 receptor
RxNorm normalized name: Interleukin-1 receptor antagonist anakinra
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Interleukin-1 receptor antagonism as adjunct therapy
Trial: 36060517
Drug: TP (docetaxel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TP (docetaxel 75 mg/m², cisplatin 75 mg/m²)
Trial: 36060517
Drug: TPF (docetaxel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TPF (docetaxel 60 mg/m², cisplatin 60 mg/m², 5-fluorouracil 600 mg/m²)
Trial: 33878462
Drug: Diphenhydramine Compound
RxNorm normalized name: diphenhydrAMINE compounding powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphenhydramine Compound (Diphenhydramine + Ammonium Chloride) plus standard of care
Trial: 34788694
Drug: Lefamulin 150
RxNorm normalized name: lefamulin 150 MG in 15 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lefamulin 150 mg IV q12h for 5-7 days
Trial: 34788694
Drug: Moxifloxacin 400
RxNorm normalized name: moxifloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxifloxacin 400 mg IV q24h for 7 days
Trial: 34788694
Drug: Lefamulin 600
RxNorm normalized name: lefamulin 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lefamulin 600 mg oral q12h for 5 days
Trial: 34788694
Drug: Moxifloxacin 400
RxNorm normalized name: moxifloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxifloxacin 400 mg oral q24h for 7 days
Trial: 35233731
Drug: Inhaled triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled triple therapy (once daily)
Trial: 35233731
Drug: Inhaled dual
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled dual therapy (twice daily)
Trial: 32394658
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment (at Baihui (GV 20), Guanyuan (CV 4), Qihai (CV 6), Fengchi (GB 20), Zusanli (ST 36), Sanyinjiao (SP 6)), once a day, 5 times as one course, with 2 days interval between each course, total of 4 courses.
Trial: 32394658
Drug: Conventional chemoradiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional chemoradiotherapy and symptomatic treatment (control group).
Trial: 34784804
Drug: Focused shockwave
RxNorm normalized name: AVOBENZONE 0.2 g in 1 g / BUTYLENE GLYCOL 0.1 g in 1 g TOPICAL CREAM [Focused Corrective]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Focused shockwave therapy (f‐ESWT)
Trial: 32466231
Drug: Taurine supplementation
RxNorm normalized name: Taurine
DrugBank: Taurine (DB01956)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Taurine supplementation (6 g)
Trial: 32030845
Drug: Ultrasound-guided posterior
RxNorm normalized name: posterior pituitary hormones
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided posterior quadratus lumborum block with 0.25% bupivacaine 0.5 mL/kg
Trial: 32030845
Drug: Ultrasound-guided ilioinguinal/iliohypogastric
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided ilioinguinal/iliohypogastric nerve block with 0.25% bupivacaine 0.2 mL/kg
Trial: 34838980
Drug: Sarcojoint® 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sarcojoint® 1 package twice a day
Trial: 35357103
Drug: Insulin addition
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin addition to total nutrition admixture (TNA)
Trial: 34082090
Drug: Typbar TCV®
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Typbar TCV® co-administered with MR and YF vaccines (Group 1)
Trial: 34082090
Drug: Inactivated polio
RxNorm normalized name: Inactivated polio vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated polio vaccine (IPV) co-administered with MR and YF vaccines (Group 2)
Trial: 33044710
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg Cu/kg as Cu-Lys-Glu
Trial: 33044710
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg Cu/kg as Cu-Lys-Glu
Trial: 33044710
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg Cu/kg as Cu-Lys-Glu
Trial: 33044710
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg Cu/kg as Cu-Lys-Glu
Trial: 33044710
Drug: 0 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg Cu/kg as Cu-Lys-Glu (control)
Trial: 32901234
Drug: Complete Care
RxNorm normalized name: Pepsodent Complete Care Toothpaste
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complete Care toothpaste (CC; Himalaya)
Trial: 36259302
Drug: Equicrestal placement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Equicrestal placement of dental implants (Group I)
Trial: 36259302
Drug: Subcrestal placement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcrestal placement of dental implants (Group II)
Trial: 32367375
Drug: CONS (conservative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CONS (conservative treatment)
Trial: 36522767
Drug: Intravenous morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous morphine alone
Trial: 32720552
Drug: Er:YAG laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Er:YAG laser treatment (3 treatments at monthly intervals)
Trial: 32720552
Drug: Watchful waiting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Watchful waiting (no treatment)
Trial: 34385236
Drug: Point-of-care (PoC)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Point-of-care (PoC) testing and immediate treatment of curable STIs
Trial: 32954487
Drug: 800 mg/day
RxNorm normalized name: RibaTab 800 mg/day Compliance Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg/day of pharmaceutical-grade chondroitin sulfate (CS)
Trial: 33926446
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine U300 (IGlar‐300)
Trial: 33926446
Drug: Insulin degludec
RxNorm normalized name: Insulin Degludec
DrugBank: Insulin degludec (DB09564)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Insulin degludec U100 (IDeg‐100)
Trial: 33046094
Drug: Medicines and
RxNorm normalized name: Percy Medicine
DrugBank: Bismuth subsalicylate (DB01294)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medicines and Alcohol Consultation (MAC) delivered by trained community pharmacists (n=5) during Medicine Use Review (MUR) and New Medicine Service (NMS) consultations.
Trial: 36002548
Drug: 1250 mg
RxNorm normalized name: bran 1250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1250 mg of β-nicotinamide mononucleotide (β-NMN) administered orally once daily for up to 4 weeks
Trial: 35278903
Drug: Savlon antiseptic
RxNorm normalized name: Listerine Antiseptic
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Savlon antiseptic cream
Trial: 35278903
Drug: Soap and
RxNorm normalized name: Green soap and industrial methylated spirit only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soap and water treatment
Trial: 36113531
Drug: One dose
RxNorm normalized name: Next Choice One Dose
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: One dose of Cervarix
Trial: 36113531
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of Cervarix
Trial: 36113531
Drug: Three doses
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three doses of Cervarix
Trial: 36113531
Drug: One dose
RxNorm normalized name: Next Choice One Dose
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: One dose of Gardasil-9
Trial: 36113531
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of Gardasil-9
Trial: 36113531
Drug: Three doses
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three doses of Gardasil-9
Trial: 33072214
Drug: ProTaper Universal
RxNorm normalized name: STATLOCK UNIVERSAL PLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ProTaper Universal files (Dentsply Maillefer) used in rotary preparation
Trial: 33072214
Drug: Failures during
RxNorm normalized name: INVESTIGATIONAL CONGESTIVE HEART FAILURE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Failures during rotary preparation
Trial: 35501569
Drug: Routine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine treatment protocol (Control)
Trial: 32603336
Drug: Soft tissue
RxNorm normalized name: INSULIN DETEMIR 14.2 mg in 1 mL SOFT TISSUE IMPLANT [Levemir]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soft tissue therapy (STT) techniques for the masseter muscle
Trial: 35723225
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (metformin/insulin/glipizide)
Trial: 34684508
Drug: Wahls diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wahls diet (including supplements)
Trial: 34684508
Drug: Both diets
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both diets (including supplements)
Trial: 36074965
Drug: Blessed TRI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blessed TRI 360TM capsule (Biofield Energy Treated Proprietary Dietary Supplement) taken twice a day (morning and evening)
Trial: 36074965
Drug: Placebo control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo control (no treatment/capsule)
Trial: 36074965
Drug: Blessed TRI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blessed TRI 360TM capsule